Hypocomplementemia C3 and anti-SSB positivity: associated factors and a predictive model for hematological involvement in Sjögren’s disease

Objective Hematological involvement occurs in over 20% of patients with Sjögren’s disease (SjD), yet its associated factors remain poorly characterized. This retrospective cross-sectional study aimed to evaluate clinical and immunological factors associated with concurrent hematological involvement in SjD using blood cell damage stratification. Methods A total of 163 hospitalized SjD patients without recent high-dose glucocorticoids or potent immunosuppressants (2018–2024) were enrolled. Demographic data, clinical characteristics, laboratory parameters, and disease activity indices were collected. Patients were classified into two groups based on the presence or absence of baseline hematological involvement. Multivariable logistic regression identified factors independently associated with concurrent hematological involvement and constructed a cross-sectional classification model. The model’s discriminative performance was evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Results Among 163 enrolled SjD patients, 70 (42.9%) had hematological involvement, while 93 (57.1%) did not. Compared with patients without hematological involvement, those with involvement had significantly higher levels of globulin (median 40 vs. 33 g/L), IgG (median 18.0 vs. 15.5 g/L), and modified ESSDAI scores (excluding the hematological domain, median 9.0 vs. 6.0), as well as lower C3 (median 0.74 vs. 0.86 g/L) and C4 levels (median 0.16 vs. 0.18 g/L) (all P < 0.05). Patients with multilineage cytopenia exhibited elevated IgG levels, increased disease activity, higher anti-SSB positivity rates, and reduced C3 levels. C3 hypocomplementemia (OR 0.21, 95% CI 0.02–2.67, P < 0.05) and anti-SSB positivity (OR 6.61, 95% CI 1.59–110, P < 0.05) were independently associated with concurrent hematological involvement. The combined model incorporating C3 and anti-SSB antibody yielded an AUC of 0.741 (95% CI: 0.642–0.841), outperforming either C3 (AUC = 0.633) or anti-SSB antibody (AUC = 0.656) when used alone. At the optimal cut-off value, the sensitivity and specificity were 76.7% and 68.4%, respectively. Conclusion C3 hypocomplementemia and anti-SSB positivity are independently associated with hematological involvement in SjD, and their combination may serve as a preliminary cross-sectional tool for identifying such patients at initial evaluation, pending external validation. Routine C3 and anti-SSB measurement may be a useful, accessible marker for raising suspicion of cytopenia in clinical practice.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-13
DOI
https://doi.org/10.3389/fimmu.2026.1928854
Primary Topic
Salivary Gland Disorders and Functions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hypocomplementemia C3 and anti-SSB positivity: associated factors and a predictive model for hematological involvement in Sjögren’s disease

Leixi Xue, Chenghua Weng, Enzhuo Liu, Xiya Wen et al.
1 links
Frontiers in Immunology
Salivary Gland Disorders and Functions
article

Hypocomplementemia C3 and anti-SSB positivity: associated factors and a predictive model for hematological involvement in Sjögren’s disease

Leixi Xue, Chenghua Weng, Enzhuo Liu, Xiya Wen, Zhichun Liu, Yujie Zhang, Lei Li, Xinyue Li, Lina An
article en

Abstract

Objective Hematological involvement occurs in over 20% of patients with Sjögren’s disease (SjD), yet its associated factors remain poorly characterized. This retrospective cross-sectional study aimed to evaluate clinical and immunological factors associated with concurrent hematological involvement in SjD using blood cell damage stratification. Methods A total of 163 hospitalized SjD patients without recent high-dose glucocorticoids or potent immunosuppressants (2018–2024) were enrolled. Demographic data, clinical characteristics, laboratory parameters, and disease activity indices were collected. Patients were classified into two groups based on the presence or absence of baseline hematological involvement. Multivariable logistic regression identified factors independently associated with concurrent hematological involvement and constructed a cross-sectional classification model. The model’s discriminative performance was evaluated using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Results Among 163 enrolled SjD patients, 70 (42.9%) had hematological involvement, while 93 (57.1%) did not. Compared with patients without hematological involvement, those with involvement had significantly higher levels of globulin (median 40 vs. 33 g/L), IgG (median 18.0 vs. 15.5 g/L), and modified ESSDAI scores (excluding the hematological domain, median 9.0 vs. 6.0), as well as lower C3 (median 0.74 vs. 0.86 g/L) and C4 levels (median 0.16 vs. 0.18 g/L) (all P < 0.05). Patients with multilineage cytopenia exhibited elevated IgG levels, increased disease activity, higher anti-SSB positivity rates, and reduced C3 levels. C3 hypocomplementemia (OR 0.21, 95% CI 0.02–2.67, P < 0.05) and anti-SSB positivity (OR 6.61, 95% CI 1.59–110, P < 0.05) were independently associated with concurrent hematological involvement. The combined model incorporating C3 and anti-SSB antibody yielded an AUC of 0.741 (95% CI: 0.642–0.841), outperforming either C3 (AUC = 0.633) or anti-SSB antibody (AUC = 0.656) when used alone. At the optimal cut-off value, the sensitivity and specificity were 76.7% and 68.4%, respectively. Conclusion C3 hypocomplementemia and anti-SSB positivity are independently associated with hematological involvement in SjD, and their combination may serve as a preliminary cross-sectional tool for identifying such patients at initial evaluation, pending external validation. Routine C3 and anti-SSB measurement may be a useful, accessible marker for raising suspicion of cytopenia in clinical practice.

Frontiers in ImmunologyVol. 17
Second Affiliated Hospital of Soochow University (CN)
Good health and well-being
Salivary Gland Disorders and Functions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon